Ann: Harvest One Operational Update, page-15

Can somebody clarify this for me please?
"Satipharm’s Gelpell-CBD™ capsules are suitable for the treatment of a variety of medical conditions and are only available through the Therapeutic Goods Administration (TGA) Special Access Scheme (Cat B) or through the Authorised Prescriber scheme"

is the Gelpell capsules TGA approved!???   if yes then bloody hell,  Satipharm is going to make killa $$$$ and MMJ market cap should be in the $100s of millions.  

Forget about Cresco or CAN  or Ac8 ,   MMJ is going to be the Pfizer of Cannibas in Australia if they already got the TGA approval for the Gelpell.

I need to clarify this before I start buying // can someone help please?